Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Changes in the quality of life of people with thalassemia major between 2001 and 2009.

Gollo G, Savioli G, Balocco M, Venturino C, Boeri E, Costantini M, Forni GL.

Patient Prefer Adherence. 2013;7:231-6. doi: 10.2147/PPA.S42133. Epub 2013 Mar 20.


Role of liposomal daunorubicin, fludarabine and cytarabine (FLAD) in the salvage therapy of adult acute lymphoblastic leukemia.

Clavio M, Pierri I, Venturino C, Garrone A, Canepa L, Miglino M, Varaldo R, Ballerini F, Michelis GL, Balocco M, Abdall N, Gatto S, Gobbi M.

Leuk Lymphoma. 2004 Dec;45(12):2527-30. No abstract available.


Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.

Poggi A, Venturino C, Catellani S, Clavio M, Miglino M, Gobbi M, Steinle A, Ghia P, Stella S, Caligaris-Cappio F, Zocchi MR.

Cancer Res. 2004 Dec 15;64(24):9172-9.


Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.

Clavio M, Venturino C, Pierri I, Garrone A, Miglino M, Canepa L, Balleari E, Balocco M, Michelis GL, Ballerini F, Gobbi M.

Ann Hematol. 2004 Nov;83(11):696-703. Epub 2004 Aug 18.


Quality of life and brain function following high-dose recombinant human erythropoietin in low-risk myelodysplastic syndromes: a preliminary report.

Clavio M, Nobili F, Balleari E, Girtler N, Ballerini F, Vitali P, Rosati P, Venturino C, Varaldo R, Gobbi M, Ghio R, Rodriguez G.

Eur J Haematol. 2004 Feb;72(2):113-20.


Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients.

Clavio M, Gatto S, Beltrami G, Quintino S, Canepa L, Pierri I, Galbusera V, Carrara P, Miglino M, Varaldo R, Ballerini F, Venturino C, Cerri R, Risso M, Balleari E, Carella AM, Sessarego M, Ghio R, Bacigalupo A, Gobbi M.

J Exp Clin Cancer Res. 2002 Dec;21(4):481-7.


Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment?

Clavio M, Quintino S, Venturino C, Ballerini F, Varaldo R, Gatto S, Galbusera V, Garrone A, Grasso R, Canepa L, Miglino M, Pierri I, Gobbi M.

J Exp Clin Cancer Res. 2001 Sep;20(3):351-8. Review.


Supplemental Content

Loading ...
Support Center